logo
Health Check: Records tumble as biotech's star quarterly reporters pick up the pace

Health Check: Records tumble as biotech's star quarterly reporters pick up the pace

News.com.au6 days ago
• Several emerging life science plays are taking revenue to new heights – and some have even turned profitable
• Little Green Pharma seeks to avoid a second pay 'strike'
• Althea founder exits the building
It is a truth, universally acknowledged, that biotechs with little or no revenue and cascading cash outflows will leave their quarterly disclosures to the last possible moment.
Given dozens of other companies holding off until around July 31 – the deadline for lodging June quarterlies – this crowds out the bad news.
The corollary is that those with pleasant surprises prefer to break with the hoi polio and go early.
True to trend, today's reporters have broken more sales records than our Glasgow-bound Gout Gout.
In fact, the last time your columnist heard so much about records was in a Brashs store in the 1980s … which dates him somewhat.
The company (and patient) are doing well
The provider of software to make hospitals run more smoothly, Alcidion (ASX:ALC) reports record quarterly cash flow of $7.4 million for the quarter.
This takes the year's surplus to $5.8 million (also an all-time high).
Full-year receipts came in at $50.9 million, 16% higher.
Alcidion provides software to hospitals – such as patient workflow tools – to enable them to run more smoothly and prevent surgeons from amputating the wrong leg.
The company has a meaningful local and UK presence across 400 hospitals and 87 healthcare organisations.
Management reports new June quarter sales of $6.7 million, 73% of which are recurring.
The company also affirms underlying earnings of $4.5 million for the 2024-25 year, upped from $3 million in June.
This should be confirmed at August's full year results prezzo.
Hear! Hear! A record year for Audeara
The maker of hearing augmentation devices, Audeara (ASX:AUA) reports June quarter revenue of $722,000, which takes full-year turnover to a record $3.78 million (up 22%).
Audeara own-branded headphones are sold via hearing clinics.
But the company has skewed its business to its AUA Technology arm, which has an 'Intel inside' model of providing the technology to big-ticket international customers.
These include the 400-year-old US instrument maker, Avedis Zildjian.
Audeara founder and CEO Dr James Fielding dubs the quarter as a 'period of consolidation'.
He says the company 'executed on several strategic initiatives to ensure it capitalises on the growth established through the AUA Technology division over the previous 12 months".
Audeara also had $757,000 of cash outflows for the quarter, reducing June-end cash to $1.42 million.
But Fielding says the company should see a 'material uplift' in current quarter revenues, owing to a chunky Avedis Zildjian re-order.
Bioxyne eyes European growth
A supplier of cannabis and psychedelic meds, Bioxyne (ASX:BXN) more than doubled full-year revenue to $9.55 million, with full-year revenue up 215% to $29.3 million.
Did we mention that was a record?
The company also managed positive cash flow of $1.5 million for the June stanza.
This takes the full-year cash flow to $6.2 million, compared to a $3.6 million deficit in 2023-24.
Management attributes the surge to the Australian operating of its subsidiary Breathe Life Sciences.
But Bioxyne's greater growth prospects lie with the UK and European markets, notably Germany where it has inked two key manufacturing and supply agreements.
Little Green faces big pay votes
Still on pot stocks, Little Green Pharma (ASX:LGP) again faces the music on two remuneration-related motions at its August 21 AGM.
As a March balance date entity, Little Green beats the usual AGM rush.
Last year, 83% of voting shares were cast against Little Green's 'rem' report, well beyond the 25% 'no' vote threshold.
If investors again knock back the proposal, they'll vote on a motion to spill the board (this one requires a minimum 50% 'yes' vote).
The board has also reprised last year's proposal to accelerate the vesting of management and executive share incentives, in the event of the "person ceasing to hold such office."
Investors overwhelmingly opposed this one last time as well.
Thorney Investments is Little Green's biggest shareholder on 19.7%.
Gina Rinehart's Hancock Prospecting supported a 2021 capital raising and emerged with 10%. But it's not clear how much she holds now.
Althea founder bows out
We're not obsessed with cannabis – that's a promise – but it behooves us to report that Althea Group (ASX:AGH) founder and CEO Josh Fegan has left the company, with 'immediate effect'.
Fegan created Althea in 2016 and the company listed in September 2018. Fegan had been at the helm all that time.
As we reported on Wednesday, Althea has given up on the over-competed local medicinal pot sector.
The company now is focusing on the North American recreational market via its subsidiary Peak Processing.
Specifically, Peak is getting into THC-laced beverages as an alternative to alcoholic ones.
Althea share tumbled 10% on the surprise tidings.
On Bell Potter's gut feel, Microba's worth much more
Bell Potter reckons there's 60% share price upside in Microba Life Sciences (ASX:MAP), which provides microbiome testing.
Microba on Wednesday reported a 13% June quarter revenue decline, to $4.2 million.
But stripping out the divestment of a legacy research business, revenue grew 4% year-on-year.
Microba has two core products: Metaxplore and Metapanel.
Metapanel is the 'first line' test to determine whether a doc can treat a pathogen simply with antibiotics.
Metaxplore probes anything else that could be wrong with the patient's microbiome.
The company has free cash flow burn of $6.3 million for the quarter and $15.3 million for the year. But this rate has been 'relatively steady' over the last two years.
Following a $14.5m capital raising – backed by biggest shareholder Sonic Healthcare – Microba has $20.2 million of cash with no debt.
"Most legacy sales have now unwound, so we anticipate more meaningful consolidated topline growth for the group in 2025-26," Bell Potter says.
The forecasts an adjusted net loss of $14.6 million for 2024-25 and a simialar deficit this year.
The company expects to break even in 2027-28.
Bell Potter values stock at 16 cents, tempered from its previous 26 cent guesstimate.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Good enough': ASX jumps on positive inflation reading
‘Good enough': ASX jumps on positive inflation reading

News.com.au

timean hour ago

  • News.com.au

‘Good enough': ASX jumps on positive inflation reading

Banks, property and supermarket shares drove the ASX to a near record high on Wednesday after quarterly inflation all but confirmed an interest-rate cut when the Reserve Bank of Australia board meets in August. The benchmark ASX 200 jumped 51.80 points or 0.60 per cent to 8,756.40, with the market lifting after 11.30am on the CPI data from the Australian Bureau of Statistics. The broader All Ordinaries also traded higher up 48.70 points or 0.54 per cent to 9,015.40. Australia's dollar slid on the news down 0.05 per cent to US 65.09 cents. Six of the 11 sectors finished in the green. Shares related to a rate cut jumped on the news. Gains were led by the major banks with bourse heavyweight CBA up 1.55 per cent to $176.99, NAB gained 0.71 per cent to $38.47, Westpac jumped 1.60 per cent to $33.72 and ANZ closed 1.25 per cent higher to $30.70. Woolworths Group added 1.58 per cent to $31.44, Coles jumped 1.72 per cent to $20.65 and Endeavour Group is up 1.23 per cent to $4.12. Stockland shares jumped 2.21 per cent to $5.55, Charter Hall Group gained 1.76 per cent to $20.21 and Mirvac Group gained 2.73 per cent to $2.26. Betashare chief economist David Bassanese said near enough was good enough for a rate cut as trimmed mean inflation fell to 2.7 per cent for the 12 months until June. 'Underlying inflation is inching closer to the middle of the RBA's 2 to 3 per cent target band and so justifies a further easing in what – in the RBA's own words – a still 'modestly restrictive' level of interest rates,' he said. Josh Gilbert, market analyst for eToro, described it as hard for the RBA to hold rates. 'After the surprise pause in July, today's data means an August rate cut is all but nailed on,' he said. 'Markets are now pricing a 93 per cent chance of a cut, and it's easy to see why. Cost-of-living pressures are easing, and the risk is now skewed towards holding rates too high for too long.' In company news, Rio Tinto half-yearly earnings fell to a five-year low on the back of weaker iron ore prices throughout the previous six months. The major iron ore exporter told the market its underlying profits came in at $US4.8bn for the first six months until June 30, which is down from $US5.75bn ($8.83bn) last year Interim dividends fall to $US1.48 a share versus $1.77 a year ago Embattled casino operator Star Entertainment used its quarterly update to announce the sale of its Queen's Wharf precinct in Brisbane was 'unlikely' to go through by Thursday's deadline. But it also pointed to an improving cash position with Star having $234m in cash and $269m in cash equivalents, as of June 30, up from $44m at the end of March. Shares in Star Entertainment Group slumped 4.35 per cent to $0.11 following the announcement.

Resources Top 5: Gold results point to much bigger Little Gem for Ora Banda
Resources Top 5: Gold results point to much bigger Little Gem for Ora Banda

News.com.au

timean hour ago

  • News.com.au

Resources Top 5: Gold results point to much bigger Little Gem for Ora Banda

OBM's expansive plan to extend the life of its Davyhurst gold operations is taking shape PIM has received commitments to raise $1.76m in a placement to sophisticated and professional investors The iron ore potential of CuFe's Camp Creek project in the NT has been enhanced by high-grade samples Your standout small cap resources stocks for Wednesday, July 30, 2025 Ora Banda (ASX:OBM) The signs point to Ora Banda having more than just a Little Gem on its hands as its expansive plan to extend the life of its Davyhurst gold operations in WA takes shape. High-grade gold results from phase 2 drilling of up to 8.8m at 6.3g/t from 320m below surface have extended the multi-lode gold system at Little Gem prospect to a strike of more than 1km. The gold producer is not scrimping on the task with $73m budgeted to deliver an extraordinary 329km of drilling in FY26, which is double the past three years of drilling activity combined. This major spend will underpin mine life extension at Riverina and Sand King underground mines, assess whether the Waihi deposit can be taken underground, advance the Little Gem, Round Dam and Mulline prospects, and pursue belt-wide exploration over 140km of tenure. It is little wonder that it is spending up as the previous spend saw 189km drilled to identify two now developed underground mines and numerous advanced targets. Ora Banda Mining increased 9.5% to 74.5c with more than 12m shares changing hands valued at $9m. The company's quest to find more gold is proving fruitful, with the latest 16-hole program at Little Gem confirming high gold grades and large lode widths. Four lodes have been modelled – Diamond, Ruby, Sapphire and Tanzanite – and the 8.8m intersection in LGDD25008 is a 400-metre step out to the north of LGDD25005 which previously returned 22.7m at 5.0g/t. OBM said this showed the prospective strike of a well-developed high-grade shoot on the Diamond Lode was more than 1,000 metres and remained open at depth. While only in the early stage of drill testing, the company is confident of the greenfields potential of the Little Gem-Sunraysia system and has started a phase 3 follow up program. This will see 38 holes drilled with two diamond rigs and one RC rig active targeting the Diamond and Ruby lodes down to 500 metres, with some deeper drill testing of the system down to 750 metres below surface planned. Other lodes will be tested over the course of FY26. Pinnacle Minerals (ASX:PIM) With a primary focus on lithium, it has been a period of relative dormancy for Pinnacle Minerals but with signs pointing to a positive future and improving prices, the company is well placed for growth. As well as its battery metals projects in Canada, headed by the Adina East lithium project in Quebec, technology minerals in Australia, including rare earths in South Australia and heavy minerals in WA, strengthen the company's foundation. Pinnacle, which also continues to evaluate and pursue other strategic opportunities, has reached 5.6c, an increase of 40% on a pre-trading halt close. The halt was lifted after the company announced that it has received firm commitments to raise approximately $1.76m before costs in a two-tranche placement to sophisticated and professional investors. New shares will be issued at 4c per share, with one free attaching option issued for every two new shares subscribed. The options will be exercisable at 8c and will expire three years from the date of issue. Pinnacle also intends to offer a bonus option entitlement issue to existing shareholders as a reward for their continued support. Funds raised under the placement will be used to: Advance the company's exploration programs in Canada and Australia; support general working capital requirements; and provide flexibility to evaluate and pursue strategic opportunities. The placement will be completed in two tranches: Tranche 1 – Comprising the issue of 11,365,815 shares to raise about $454,632, utilising the company's existing placement capacity under ASX Listing Rules 7.1 and 7.1A. Tranche 2 – Comprising the issue of 32,634,185 shares to raise about $1,305,367, subject to shareholder approval at a general meeting on or around September 15, 2025. The placement was jointly managed by AE Advisors and Oakley Capital Partners. CuFe (ASX:CUF) The iron ore potential of the NT's north has been enhanced by CuFe with a review and fieldwork identifying samples assaying 68.78% and 67.91% Fe at Camp Creek project in proximity to its Yarram resource. This work has seen CuFe (ASX:CUF) reach a 12-month high of 1.2c, a lift of 20% on the previous close. The review showed the best assay in samples gathered by previous explorers between 2013 and 2018 graded 68.78% Fe and has defined three target areas for further exploration. In June 2025 a one-day field reconnaissance was held to validate the historical sampling and assess outcropping mineralisation, focusing on one of the three targets. Fifteen rock chip samples were collected, with 10 from iron-enriched outcrops returning assays exceeding 60% Fe, including a maximum of 67.91%. CuFe interprets these results as encouraging evidence of EL33835's potential to host high-grade iron mineralisation, enhanced by its closeness to Yarram, which is 5km away and has an inferred resource of 12.7Mt at 55.4% Fe. CUF plans to advance Camp Creek with further mapping and sampling across remaining target areas to guide future drill targeting. Green Critical Minerals (ASX:GCM) To capitalise on increasing US demand for advanced thermal management solutions, including its very high-density graphite blocks, Green Critical Minerals is seeking to list on a US exchange to complement its ASX listing. This will enable the company to access a broad customer base, engage directly with leading technology manufacturers and tap into one of the world's deepest and most sophisticated capital markets. It will also unlock substantial commercial value through partnerships, distribution networks and market share expansion. This move follows GCM setting up a US entity to support product registration requirements, streamline logistics and enable direct engagement with North American customers in the advanced electronics, semiconductor and infrastructure sectors. Green Critical Minerals is evaluating the most effective pathway for a US market entry with consideration given to the most suitable exchange – either the NYSE or Nasdaq – and has engaged leading legal advisors HWL Ebsworth to support this process. It has also formed a dedicated selection committee tasked with advancing advisor and investment bank appointments. Trigg Minerals (ASX:TMG) To strengthen its focus on developing domestic processing capability for critical minerals in the United States, Trigg Minerals (ASX:TMG) has appointed US-based special purpose acquisition company (SPAC) veteran James Graf as a non-executive director. The company's US efforts are centred on the flagship Antimony Canyon Project in Utah while it also has antimony interests in Australia. Graf has more than 35 years of international capital markets, M&A and corporate management experience and will assist Trigg as it advances plans for a US mainboard listing. He is currently CEO of Graf Global Corp, his eighth SPAC as CEO, CFO and/or active director. He also serves as interim CFO of NKGen Biotech, his last SPAC target. Trigg will leverage his deep cross-border experience in banking and SPACs, including resources transactions and Australian deals, to sharpen its execution strategy and build strong engagement with US investors. 'Antimony Canyon Project is a globally unique asset and the addition of James to the team is an exciting step in the development of Trigg Minerals,' chairman Timothy Morrison said. This article does not constitute financial product advice. You should consider obtaining independent financial advice before making any financial decisions. While Ora Banda Mining, CuFe, Green Critical Minerals and Trigg Minerals are Stockhead advertisers, they did not sponsor this article.

Australian-made rocket crashes after attempted north Queensland launch
Australian-made rocket crashes after attempted north Queensland launch

ABC News

timean hour ago

  • ABC News

Australian-made rocket crashes after attempted north Queensland launch

An Australian-designed and manufactured rocket has lifted off in the first launch attempt from home soil, though it crashed shortly after. Gilmour Space Technologies attempted to launch its orbital rocket, called Eris, from a spaceport in the north Queensland community of Bowen on Wednesday morning. The rocket was in the air for less than a minute. Spectators who gathered in Bowen reported hearing a blast and seeing large plumes of smoke at the launch and for some time after. Co-founder Adam Gilmour posted to social media that the company was happy with the launch attempt. "Got off the pad, I am happy," he wrote. "Of course I would have liked more flight time but happy with this." Gilmour Space released a statement with further information celebrating the unprecedented event. "Today, Eris became the first Australian made orbital launch vehicle to lift off from Australian soil," the statement read. "For a maiden test flight, especially after an extended 18-month wait on the pad for approvals, this is a strong result and a major step forward for Australia's sovereign space capability." The company said Eris had 23 seconds of engine burn time and 14 seconds of flight. Initial assessments of the Bowen Orbital Spaceport found launch infrastructure intact. The Gold Coast company tried to proceed with launch attemptsseveral times this year but was hampered by weather and technical issues. Gold Coast Mayor Tom Tate congratulated the company. "Congratulations to Gilmour Space Technologies on having a crack. They truly exemplify the Gold Coast 'have a go' spirit," Cr Tate said. "They are literally a Gold Coast company aiming for the stars. If you ever wanted an example of how diversified our economy is now, this is it. "We look forward to following their progress in the years ahead." 'Part of history' For Mackay resident Andrew Hyland, this was his third trip to Bowen to witness the rocket take-off. "I've been up here since the first launch was programmed to go," he said. "Being Australia's first launch in 50 years and first Australian-made … it's part of history, you can't miss out on history." Bowen residents Helen and Douglas Tawse were ready to watch the rocket take off from the beach. Ms Tawse said the launch would "put Bowen on the map". Mr Tawse said the launch could generate benefits for the small north Queensland community. "I never thought I'd ever see the day," Mr Tawse said. "If they're talking about more satellites going up, it would have to help Bowen's economy in the long term." Pointed towards the sky, this Australian-first rocket is set to blast a small town into the global spotlight Photo shows A rocket on scaffolding is lifted up on a launch pad. It's taken the Gilmour brothers nearly 10 years to build and design a locally made orbital rocket. Space enthusiasts are set to flock to north Queensland to see it lift off. 'Burgeoning commercial' industry Gilmour Space Technologies has received Australian Government support for its Bowen project, including $5 million for the Eris launch vehicle announced last week. University of Southern Queensland astrobiologist and astronomer, Jonti Horner, said the launch of the Eris rocket was exciting and showed a maturation of the space industry. Professor Horner said that historically, only government-run space agencies had the capability to launch rockets. "In the last decade or so, there has been very much an explosion in our use of space, and that's been because there has been a shift to commercial capacity to put things into orbit," he said. "As soon as it becomes a commercial enterprise, that means the technology is now much more mature and the prices drop hugely, and there is now this burgeoning global industry of commercial spaceflight and the commercial use of space." Gilmour Space Technologies cut its May launch campaign short after staff reported two anomalies on different days. The first was a power supply issue, and the second was the premature opening of the spacecraft's payload fairing, or nose cone. The company hopes to eventually send satellites into orbit from Australia for commercial entities and the government.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store